351 related articles for article (PubMed ID: 19628654)
1. Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model.
Theodorakis NG; Wang YN; Wu JM; Maluccio MA; Sitzmann JV; Skill NJ
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G792-9. PubMed ID: 19628654
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
Theodorakis NG; Wang YN; Korshunov VA; Maluccio MA; Skill NJ
World J Gastroenterol; 2015 Apr; 21(14):4126-35. PubMed ID: 25892862
[TBL] [Abstract][Full Text] [Related]
3. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
[TBL] [Abstract][Full Text] [Related]
4. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
Xu J; Cao H; Liu H; Wu ZY
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
[TBL] [Abstract][Full Text] [Related]
6. Murine study of portal hypertension associated endothelin-1 hypo-response.
Theodorakis N; Maluccio M; Skill N
World J Gastroenterol; 2015 Apr; 21(16):4817-28. PubMed ID: 25944995
[TBL] [Abstract][Full Text] [Related]
7. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
8. Deleterious effects of silymarin on the expression of genes controlling endothelial nitric oxide synthase activity in carbon tetrachloride-treated rat livers.
Cho YK; Yun JW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Jin W; Kwon YH; Shin MK; Yoo TM; Kang JH; Park CS
Life Sci; 2009 Aug; 85(7-8):281-90. PubMed ID: 19527736
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin effects on portal-systemic collaterals of portal hypertensive rats.
Huang HC; Wang SS; Lee JY; Chen YC; Lee FY; Lin HC; Chang CC; Lee SD
J Gastroenterol Hepatol; 2010 Aug; 25(8):1401-9. PubMed ID: 20659230
[TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase is not essential for the development of fibrosis and liver damage induced by CCl4 in mice.
Moreno MG; Muriel P
J Appl Toxicol; 2006; 26(4):326-32. PubMed ID: 16705756
[TBL] [Abstract][Full Text] [Related]
12. Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice.
Bexis S; Vandeputte C; McCormick PA; Docherty JR
Eur J Pharmacol; 2004 Sep; 499(3):325-33. PubMed ID: 15381055
[TBL] [Abstract][Full Text] [Related]
13. Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats.
Wang H; Chen XP; Qiu FZ
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):391-6. PubMed ID: 14599946
[TBL] [Abstract][Full Text] [Related]
14. Splenic hemodynamics and decreased endothelial nitric oxide synthase in the spleen of rats with liver cirrhosis.
Yamaguchi S; Kawanaka H; Yoshida D; Maehara Y; Hashizume M
Life Sci; 2007 May; 80(22):2036-44. PubMed ID: 17481668
[TBL] [Abstract][Full Text] [Related]
15. Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension.
Iwakiri Y; Cadelina G; Sessa WC; Groszmann RJ
Am J Physiol Gastrointest Liver Physiol; 2002 Nov; 283(5):G1074-81. PubMed ID: 12381520
[TBL] [Abstract][Full Text] [Related]
16. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
[TBL] [Abstract][Full Text] [Related]
17. Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state.
Abraldes JG; Iwakiri Y; Loureiro-Silva M; Haq O; Sessa WC; Groszmann RJ
Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G980-7. PubMed ID: 16603731
[TBL] [Abstract][Full Text] [Related]
18. Direct visualization of nitric oxide release by liver cells after the arrest of metastatic tumor cells in the hepatic microvasculature.
Qi K; Qiu H; Rutherford J; Zhao Y; Nance DM; Orr FW
J Surg Res; 2004 Jun; 119(1):29-35. PubMed ID: 15126078
[TBL] [Abstract][Full Text] [Related]
19. Combined use of propranolol and nifedipine offers better effects on portal vein nonuniform remodeling in carbon tetrachloride (CCl(4))-induced portal hypertensive rats.
Zhang ZQ; Shi B; Wu GQ; Qin KR; Jiang ZL; Zhu L
Eur J Pharmacol; 2009 Jun; 613(1-3):108-13. PubMed ID: 19401196
[TBL] [Abstract][Full Text] [Related]
20. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
